Author:
Ala-Hurula V.,Myllyl� V. V.,Arvela P.,K�rki N. T.,Hokkanen E.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference12 articles.
1. Ahokas, J., Myllylä, V.V., Vähäkangas, K., Nevasaari, K., Moilanen, M.-L., Kärki, N., Hokkanen, E.: Effect of ergotamine treatment on in vitro and in vivo drug metabolizing capacity and on its own biliary elimination. 11th World Congress of Neurology, Amsterdam, 1977. Amsterdam: Excerpta Medica 1978
2. Ala-Hurula, V., Myllylä, V.V., Arvela, P., Kärki, N., Hokkanen, E.: Systemic Availability of Ergotamine Tartrate after Oral, Rectal and Intramuscular Administration. Eur. J. Clin. Pharmacol.15, 51?55 (1979)
3. Bradfield, J.M.: A New Look at the Use of Ergotamine. Drugs12, 449?453 (1976)
4. Eckert, H., Kieckel, J.R., Rosenthaler, J., Schmidt, R., Schreier, E.: Biopharmaceutical aspects. Analytical methods, pharmacokinetics, metabolism and bioavailability. In: Ergot alkaloids and related compounds. Berde, E., Schild, H.O. (eds.), pp. 719?803. Berlin-Heidelberg-New York: Springer-Verlag 1978
5. Friedman, A.P., Brazil, P., v. Storch, T.J.C.: Ergotamine Tolerance in patients with Migraine. J. Am. Med. Assoc.157, 881?884 (1955)
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献